Home Home Home Inbox Home Search

Event

The RIFF Study (Cohort B): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab in Combination with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Location: PRE-FUNCTION 5-6
Session Type: Mini Symposium
Wednesday
May
23
10:45 AM
11:00 AM
Home Home Home Inbox Home Search